Stockreport

Ludwig Enterprises mRNA Bladder Cancer Study to be Launched [Yahoo! Finance]

LUDWIG ENTERPRISES  (LUDG) 
PDF the company has received Continuing Review Approval on its planned clinical study from Advarra IRB, Columbia, MD. Ludwig clinical study LL301 is titled: "Using Measureme [Read more]